AI assistant
Sending…
Q/C TECHNOLOGIES, INC. — Director's Dealing 2023
Aug 18, 2023
35313_dirs_2023-08-18_49aa8a6a-88bd-429d-9510-6be1ead3b70a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MyMD Pharmaceuticals, Inc. (MYMD)
CIK: 0001321834
Period of Report: 2023-08-17
Reporting Person: Rivard Paul (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-17 | Common stock | P | 25000 | $1.1232 | Acquired | 250000 | Direct |
More from Q/C TECHNOLOGIES, INC.
Regulatory Filings
2026
Jul 2
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 29
Annual Report
2026
Apr 15
Capital/Financing Update
2026
Feb 11
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Board/Management Information
2026
Jan 23
Regulatory Filings
2025
Dec 9
Capital/Financing Update
2025
Dec 1